𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Individually different “weights” of quality of life assessment in patients with advanced nonsmall-cell lung cancer

✍ Scribed by Satoshi Morita; Yasuo Ohashi; Kunihiko Kobayashi; Taketoshi Matsumoto; Kenji Eguchi; Masahiko Shibuya; Yasufumi Yamaji; Masahiro Fukuoka; Keiichi Nagao; Hisanobu Niitani; for the West; East CPT-11 Lung Cancer Study Groups

Book ID
117597344
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
201 KB
Volume
56
Category
Article
ISSN
0895-4356

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is quality of life predictive of the sur
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
✍ James E. Herndon II; Stewart Fleishman; Alice B. Kornblith; Michael Kosty; Mark 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Background: Several studies have recently reported on the importance of quality of life (qol) in predicting the survival of patients with lung carcinoma. to confirm these reports, the relationship between survival and qol, as measured by the european organization for research and treatment of ca

Phase 1 trial of everolimus and gefitini
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer
✍ Daniel T. Milton; Gregory J. Riely; Christopher G. Azzoli; Jorge E. Gomez; Rober 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 3 views

## Abstract ## BACKGROUND. Preclinical studies have demonstrated that the inhibition of the PI3K/Akt/mTOR pathway restores gefitinib sensitivity in resistant cancer cell lines. A phase 1 study was conducted of the combination of everolimus, an mTOR inhibitor, and gefitinib to determine a daily dos